Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etomidate versus propofol versus etomidate + propofol for anesthetic induction in hypertensive patients
IRCT20231222060494N1Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of etomidate and propofol in hypertension (HTN) (3 arms), sponsored by Ardabil University of Medical Sciences. Primary endpoints: Blood pressure and Heart rate. Started Feb 2024; status: completed.
02
Drugs
etomidatepropofol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on IRCT20231222060494N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231222060494N1.